Monday 29 October 2018

FDA Grants ‘Breakthrough’ Status to Psilocybin Mushroom Therapy for Untreatable Depression

The US Food and Drug Administration has just granted a “Breakthrough Therapy” designation to a treatment that uses psychedelic mushrooms as a therapy for treatment-resistant depression. The FDA designates a drug as a Breakthrough Therapy if preliminary clinical evidence shows that it may demonstrate substantial improvement over available therapy. Breakthrough Therapies are supported by the […]

The post FDA Grants ‘Breakthrough’ Status to Psilocybin Mushroom Therapy for Untreatable Depression appeared first on Good News Network.



from Good News Network https://ift.tt/2z9FJzD
via IFTTT

No comments: